OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ligands of the CB2 cannabinoid receptors augment activity of the conventional antidepressant drugs in the behavioural tests in mice
Ewa Poleszak, Sylwia Wośko, Karolina Sławińska, et al.
Behavioural Brain Research (2019) Vol. 378, pp. 112297-112297
Open Access | Times Cited: 14

Showing 14 citing articles:

Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
Dongchen An, Steve Peigneur, Louise Antonia Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5064-5064
Open Access | Times Cited: 165

Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
Uri Bright, Irit Akirav
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5526-5526
Open Access | Times Cited: 30

Antidepressant‐like effect of rosmarinic acid during LPS‐induced neuroinflammatory model: The potential role of cannabinoid receptors/PPAR‐γ signaling pathway
Alexandre Augusto Barros Lataliza, Pollyana Mendonça de Assis, Larissa da Rocha Laurindo, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 12, pp. 6974-6989
Closed Access | Times Cited: 26

The Novel Imipramine–Magnesium Complex Exerts Antidepressant-Like Activity in Mice Subjected to the Forced Swim Test and the Tail Suspension Test
Anna Serefko, Joanna Lachowicz-Radulska, Aleksandra Szopa, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 519-519
Open Access

Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression
Kennia Moura Silveira, Gregers Wegener, Sâmia R.L. Joca
Basic & Clinical Pharmacology & Toxicology (2021) Vol. 129, Iss. 1, pp. 3-14
Open Access | Times Cited: 19

Regulation of cannabinoid CB1 and CB2 receptors, neuroprotective mTOR and pro-apoptotic JNK1/2 kinases in postmortem prefrontal cortex of subjects with major depressive disorder
Glòria Salort, Elena Hernández‐Hernández, M. Julia García‐Fuster, et al.
Journal of Affective Disorders (2020) Vol. 276, pp. 626-635
Closed Access | Times Cited: 18

Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases
Hebaallah Mamdouh Hashiesh, Niraj Kumar Jha, Charu Sharma, et al.
European Journal of Pharmacology (2021) Vol. 909, pp. 174398-174398
Closed Access | Times Cited: 9

Uso do Canabidiol no tratamento de dor crônica neuropática em paciente com paralisia cerebral e síndrome hepatorenal policística: relato de caso
Jordana Evelin Pereira, Ana Paula Gonçalves Pinculini, Sandra Urbano dos Santos, et al.
OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA (2024) Vol. 22, Iss. 6, pp. e5038-e5038
Open Access

Role of Cannabinoid Receptors in Psychological Disorder
Ambika Nand Jha, Dhaval Patel
Borneo Journal of Pharmacy (2020) Vol. 3, Iss. 4, pp. 199-208
Open Access | Times Cited: 2

Influence of Smallanthus sonchifolius (Yacon) on the Activity of Antidepressant Drugs in Mice
Sylwia Wośko, Anna Serefko, Aleksandra Szopa, et al.
Life (2021) Vol. 11, Iss. 11, pp. 1117-1117
Open Access | Times Cited: 2

The chronic pharmacological antagonism of the CB1 receptor is not involved in the behavioral effects of antidepressants administered in mice submitted to chronic unpredictable stress
Melissa A. Ribeiro, Rafael Pazinatto Aguiar, Franciele Franco Scarante, et al.
Behavioural Brain Research (2023) Vol. 450, pp. 114502-114502
Closed Access

Page 1

Scroll to top